» Articles » PMID: 25760620

Snapshots of Ligand Entry, Malleable Binding and Induced Helical Movement in P-glycoprotein

Overview
Specialty Chemistry
Date 2015 Mar 12
PMID 25760620
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

P-glycoprotein (P-gp) is a transporter of great clinical and pharmacological significance. Several structural studies of P-gp and its homologs have provided insights into its transport cycle, but questions remain regarding how P-gp recognizes diverse substrates and how substrate binding is coupled to ATP hydrolysis. Here, four new P-gp co-crystal structures with a series of rationally designed ligands are presented. It is observed that the binding of certain ligands, including an ATP-hydrolysis stimulator, produces a large conformational change in the fourth transmembrane helix, which is positioned to potentially transmit a signal to the nucleotide-binding domains. A new ligand-binding site on the surface of P-gp facing the inner leaflet of the membrane is also described, providing vital insights regarding the entry mechanism of hydrophobic drugs and lipids into P-gp. These results represent significant advances in the understanding of how P-gp and related transporters bind and export a plethora of metabolites, antibiotics and clinically approved and pipeline drugs.

Citing Articles

Conversion of Human Multidrug Transporter P-glycoprotein (ABCB1) from Drug Efflux to Uptake Pump: Evidence for a Switch Region Modulating the Direction of Substrate Transport.

Sajid A, Ranganathan N, Guha R, Murakami M, Ahmed S, Durell S J Mol Biol. 2025; 437(7):168979.

PMID: 39900286 PMC: 11875896. DOI: 10.1016/j.jmb.2025.168979.


Structural insights into binding-site access and ligand recognition by human ABCB1.

Kurre D, Dang P, Le L, Gadkari V, Alam A EMBO J. 2025; 44(4):991-1006.

PMID: 39806099 PMC: 11833089. DOI: 10.1038/s44318-025-00361-z.


ATP-Binding Cassette and Solute Carrier Transporters: Understanding Their Mechanisms and Drug Modulation Through Structural and Modeling Approaches.

Elbahnsi A, Dudas B, Callebaut I, Hinzpeter A, Miteva M Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770445 PMC: 11676857. DOI: 10.3390/ph17121602.


Structural insight into binding site access and ligand recognition by human ABCB1.

Kurre D, Dang P, Le L, Gadkari V, Alam A bioRxiv. 2024; .

PMID: 39185192 PMC: 11343101. DOI: 10.1101/2024.08.12.607598.


Mechanistic insights into P-glycoprotein ligand transport and inhibition revealed by enhanced molecular dynamics simulations.

Elbahnsi A, Dudas B, Cisternino S, Decleves X, Miteva M Comput Struct Biotechnol J. 2024; 23():2548-2564.

PMID: 38989058 PMC: 11233806. DOI: 10.1016/j.csbj.2024.06.010.


References
1.
Loo T, Clarke D . Do drug substrates enter the common drug-binding pocket of P-glycoprotein through "gates"?. Biochem Biophys Res Commun. 2005; 329(2):419-22. DOI: 10.1016/j.bbrc.2005.01.134. View

2.
Bai J, Swartz D, Protasevich I, Brouillette C, Harrell P, Hildebrandt E . A gene optimization strategy that enhances production of fully functional P-glycoprotein in Pichia pastoris. PLoS One. 2011; 6(8):e22577. PMC: 3149604. DOI: 10.1371/journal.pone.0022577. View

3.
Krissinel E, Henrick K . Inference of macromolecular assemblies from crystalline state. J Mol Biol. 2007; 372(3):774-97. DOI: 10.1016/j.jmb.2007.05.022. View

4.
Emsley P, Lohkamp B, Scott W, Cowtan K . Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 4):486-501. PMC: 2852313. DOI: 10.1107/S0907444910007493. View

5.
Siarheyeva A, Sharom F . The ABC transporter MsbA interacts with lipid A and amphipathic drugs at different sites. Biochem J. 2009; 419(2):317-28. PMC: 2662489. DOI: 10.1042/BJ20081364. View